Therapeutic Exosomes
Exosomes for Drug Development
YM Regen focuses on developing clinically viable exosome-based therapeutics as next-generation drug delivery and treatment platforms. With our patented processes in concentration, purification, and lyophilization, we produce high-purity, bioactive exosomes optimized for clinical trials targeting unmet diseases such as acute lung injury and neurodegenerative disorders.
Moving forward, we aim to collaborate with hospitals and regulatory bodies to advance the clinical translation and commercialization of exosome-derived pharmaceuticals.